MediciNova Provides Development Update

Published January 4, 2013

MediciNova Provides Development Update

Filed under: drug rehab treatment ny

End-of-phase 2 guidance from the FDA and the newly extended patent protection (to expire no earlier than 2030) for use of MN-221 in the treatment of acute exacerbations of asthma (AEA) provide a clear development path for MN-221. Additional …
Read more on NASDAQ

Why Are So Many Doctors Misdiagnosing and Overtreating Ear Infections?

Filed under: drug rehab treatment ny

Two days later, back home in New York, our pediatrician said our son probably never had an ear infection, and that regardless, he should stop taking the drugs. At the time, I was … (The AAP is expected to release new treatment guidelines sometime …
Read more on Slate Magazine

Repligen forms partnership on spinal muscle drug

Filed under: drug rehab treatment ny

NEW YORK (AP) — Repligen Corp. said Thursday it will partner with Pfizer Inc. to pursue development of a drug designed to treat spinal muscular atrophy, a rare genetic disorder that is one of the leading causes of infant mortality. The Waltham, Mass.
Read more on Businessweek